|
ADIPOR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.156800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.554200E-01 |
| Normal-vs-Stage2 |
9.464800E-01 |
| Normal-vs-Stage3 |
8.350600E-01 |
| Normal-vs-Stage4 |
1.930290E-02 |
| Stage1-vs-Stage2 |
5.338600E-01 |
| Stage1-vs-Stage3 |
2.487000E-01 |
| Stage1-vs-Stage4 |
2.605900E-02 |
| Stage2-vs-Stage3 |
8.170200E-01 |
| Stage2-vs-Stage4 |
3.279600E-02 |
| Stage3-vs-Stage4 |
9.264800E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.453400E-01 |
| Normal-vs-AfricanAmerican |
1.230110E-02 |
| Normal-vs-Asian |
2.920200E-01 |
| Caucasian-vs-AfricanAmerican |
1.115620E-03 |
| Caucasian-vs-Asian |
3.142600E-01 |
| AfricanAmerican-vs-Asian |
4.501600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.229200E-01 |
| Normal-vs-Female |
3.703400E-01 |
| Male-vs-Female |
7.776200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.920400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.315000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.752500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.058200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.715400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.732380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.234800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.051900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.942800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.550800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.126400E-01 |
| Classical-VS-Follicular |
5.961200E-01 |
| Classical-VS-Other |
2.598700E-03 |
| Classical-VS-Normal |
1.517630E-01 |
| Tall-VS-Follicular |
7.825200E-01 |
| Tall-VS-Other |
4.942300E-02 |
| Tall-VS-Normal |
8.358000E-01 |
| Follicular-VS-Other |
8.824000E-03 |
| Follicular-VS-Normal |
5.009800E-01 |
| Other-VS-Normal |
1.236800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.965800E-01 |
| Normal-vs-N1 |
4.833800E-01 |
| N0-vs-N1 |
3.074600E-01 |
|
|
